Live today642 ASX companies on our boards · Biggest gold riser this week: Gorilla Gold Mines up 34.0%See the boards →
ASX: CU6 · Healthcare

Clarity Pharmaceuticals

Clarity Pharmaceuticals is an ASX company worth A$660.4m, trading at $1.77 on 20 Nov 2026, 55% below its 52-week high of $3.96. It has been on our leaderboards on 6 of the last 90 days. This page brings together where Clarity Pharmaceuticals sits on every Catalyst Ahead leaderboard, its share price against peers and its ASX announcements.

Close · 20 Nov
$1.77
−52.5% over 12 months
Market value
A$660.4m
from the last close
Boards today
1
leaderboards it is on
Days on boards
6
in the last 90 days
52-week range
$1.38 – $3.96
55% below the high
Shares on issue
373.1m
ASX announcements
190
in the last two years

Ask Resourceful about Clarity Pharmaceuticals

Open full Resourceful ↗
Ask about Clarity Pharmaceuticals' ASX announcements
  • What is Clarity Pharmaceuticals drilling now, and where?
  • When are Clarity Pharmaceuticals' next assay results due?
  • What did Clarity Pharmaceuticals' latest quarterly report say about cash?

Clarity Pharmaceuticals share price

Daily candles

Clarity Pharmaceuticals share price, 12 months

Clarity Pharmaceuticals 12-month share-price chart (TradingView, daily candles).

On our boards today

20 Nov 2026
On our boards on 6 days in the last 90
  • 20 Nov 2026: Did the jump stick?
  • 19 Nov 2026: Did the jump stick?
  • 18 Nov 2026: Did the jump stick?
  • 16 Nov 2026: Did the jump stick?
  • 13 Nov 2026: Did the jump stick?
  • 12 Nov 2026: Did the jump stick?
See every board live, free →

Clarity Pharmaceuticals against its peers

No share-price move for Clarity Pharmaceuticals over the last 4 weeks.

Clarity Pharmaceuticals announcements

All on the ASX ↗
DateAnnouncementAnalyse
19 Nov 2026Follow-up assessments completed in Phase III AMPLIFY trial · price sensitive
18 Nov 2026Becoming a substantial holder
12 Nov 2026First FDA Breakthrough Therapy designation in PSMA PET · price sensitive
11 Nov 2026Ceasing to be a substantial holder
11 Nov 2026Trading Halt · price sensitive
11 Nov 2026Pause in Trading · price sensitive
9 Nov 2026Becoming a substantial holder
30 Oct 2026Quarterly Activities/Appendix 4C Cash Flow Report · price sensitive
27 Oct 2026Ph III CLARIFY trial target number of participants achieved · price sensitive
23 Oct 2026Notice of Annual General Meeting/Proxy Form

Clarity Pharmaceuticals presentation and video

Latest investor presentation

No investor presentation from Clarity Pharmaceuticals on the ASX in the last two years.

Company video

Sign in to watch the latest verified Clarity Pharmaceuticals video here. It’s free. Sign in

What else moved on the ASX today

642 companies are on our live boards right now. A few that stand out:

Open today’s live boards →

Free to read, no account needed. Updated every trading day.

Board figures as of 20 Nov 2026Built from the Catalyst Ahead leaderboards and daily closes. Not financial advice.

Not financial advice. Catalyst Ahead is an AI-driven research tool. All projections are inferences from public company announcements. Always do your own research and consult a licensed adviser before trading.